Pharmaceutical Analysis & Statistics in Oceania Countries, September 2014 (p6)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

You might be interested in: therapeutics, drug, cancer, more »

151-200 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

Sigma Pharmaceuticals Limited

Sigma Pharmaceuticals Limited

  • $ 55
  • Company report
  • September 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Sigma Pharmaceuticals Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Pharmaceutical
  • Countries : Australia
Australian Pharmaceutical Industries Ltd

Australian Pharmaceutical Industries Ltd

  • $ 55
  • Company report
  • August 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Australian Pharmaceutical Industries Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

  • Industries : Pharmaceutical
  • Countries : Australia
Global Vitamin and Provitamin Market to 2018 - Market Size, Growth, and Forecasts in Nearly 70 Countries

Global Vitamin and Provitamin Market to 2018 - Market Size, Growth, and Forecasts in Nearly 70 Countries

  • $ 2 488
  • Industry report
  • July 2014
  • by MarketSizeInfo

This is a comprehensive publication that enables readers the critical perspectives to be able to evaluate the world market for vitamins and provitamins. The publication provides the market size, growth ...

  • Industries : Vitamin and Supplement
  • Countries : World, Europe, Asia, South America, Czech Republic, South Korea, Philippines, Australia, Argentina, United States, United Kingdom, Netherlands, Macedonia, Lithuania, Sri Lanka, Singapore, Kazakhstan, Indonesia, Azerbaijan, South Africa, Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Panama, Mexico, Canada, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Belgium, Austria, Vietnam, Thailand, Pakistan, Malaysia, Lebanon, Jordan, Japan, India, China, Georgia, Armenia, Senegal, Nigeria, Morocco, Ghana, Ethiopia, Egypt, North America, Peru, Oman
Analgesics Market Analysis in New Zealand

Analgesics Market Analysis in New Zealand

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

Acetaminophen accounted for 39% of analgesics current retail value sales in 2011. In addition to falling sales within acetaminophen, aspirin has also reached a very high level of maturity. Euromonito ...

  • Industries : Drug and Medication
  • Countries : New Zealand
NRT Smoking Cessation Aids Market Analysis in New Zealand

NRT Smoking Cessation Aids Market Analysis in New Zealand

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

One of the biggest changes to tobacco excise taxation over the review period occurred during 2010, when the government implemented a range of excise tax increases levied on cigarettes, cigars, cigarillos ...

  • Industries : Drug and Medication, Tobacco
  • Countries : New Zealand
Digestive Remedies Market Analysis in New Zealand

Digestive Remedies Market Analysis in New Zealand

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

Towards the latter end of the review period, consumers were extremely price conscious and this trend continued within digestive remedies during 2011. Euromonitor International's report offers a comprehensive ...

  • Industries : Over-the-counter Drug
  • Countries : New Zealand
Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in New Zealand

Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in New Zealand

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

This followed an agreement by the cabinet in September 2009 to reclassify these two drugs considering the fact they are active ingredients used in the manufacture of the Class A controlled drug methamphetamine. ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Vitamins and Dietary Supplements Market Analysis in New Zealand

Vitamins and Dietary Supplements Market Analysis in New Zealand

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

br> Euromonitor International's report offers a comprehensive guide to the size and shape of the industry at a national level. It provides the latest retail sales data from 2007 to 2011, allowing you to ...

  • Industries : Vitamin and Supplement
  • Countries : New Zealand
Chemical & Pharmaceutical Plant Construction in Australia to 2018: Market Databook

Chemical & Pharmaceutical Plant Construction in Australia to 2018: Market Databook

  • $ 500
  • Industry report
  • June 2014
  • by Timetric

Synopsis Timetric's 'Chemical & Pharmaceutical Plant Construction in Australia to 2018: Market Databook' contains detailed historic and forecast market value data for the chemical & pharmaceutical plants ...

  • Industries : Pharmaceutical
  • Countries : Australia
Dilated Cardiomyopathy - Pipeline Review, H1 2014

Dilated Cardiomyopathy - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

Dilated Cardiomyopathy - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Dilated Cardiomyopathy - Pipeline Review, H1 2014', provides an overview of the Dilated Cardiomyopathy's therapeutic ...

  • Industries : Pathology
  • Countries : World, Australia
Sienna Cancer Diagnostics Ltd - Product Pipeline Analysis, 2014 Update

Sienna Cancer Diagnostics Ltd - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

Summary Sienna Cancer Diagnostics Ltd. (Sienna) is a biotechnology company. The company commercializes diagnostic tests for the purpose of monitoring, diagnosing and evaluation of the progression of cancer. ...

  • Industries : Pathology
  • Countries : Australia
Sigma Pharmaceuticals Ltd in Retailing (Australia)

Sigma Pharmaceuticals Ltd in Retailing (Australia)

  • $ 153
  • Company report
  • June 2014
  • by Euromonitor International

After a successful redefinition of its business strategy, Sigma Pharmaceuticals has been focusing on strengthening its pharmacy-based retail business. In the first quarter of 2013, Sigma Pharmaceuticals ...

  • Industries : E-commerce, Pharmaceutical
  • Countries : Australia
MarketVIEW - Chikungunya vaccines

MarketVIEW - Chikungunya vaccines

  • $ 3 995
  • Industry report
  • June 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Chikungunya virus is an arthropod-borne RNA virus (arbovirus) which causes an acute illness including fever, skin rash, and incapacitating arthralgia. In some cases the virus can cause recurrent disease, ...

  • Industries : Drug and Medication
  • Countries : India, Japan, China, Asia, Papua New Guinea, World, United States, Bhutan, Guinea, Africa, Laos
Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia
Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom, Oceania
Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023

PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • May 2014
  • by Global Data

PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market ...

  • Industries : Pathology
  • Countries : Australia
Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan
Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
Viibryd (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Viibryd (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Viibryd (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : United States, Australia, World
PharmaPoint: Major Depressive Disorder - Current and Future Players

PharmaPoint: Major Depressive Disorder - Current and Future Players

  • $ 2 995
  • Industry report
  • May 2014
  • by Global Data

PharmaPoint: Major Depressive Disorder - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Major Depressive Disorder - Current and Future Players”. The report ...

  • Industries : Pathology
  • Countries : World, Australia
Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, United States, Spain, Italy, France, Germany, United Kingdom, Europe, Oceania
Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, Japan, World, Spain, Italy, France, Germany, United States, United Kingdom, Europe, Oceania
Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia
Fetzima (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Fetzima (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Fetzima (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : United States, World, Australia, Canada
Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom, Oceania
About 3 400 reports

Download Unlimited Documents from Trusted Public Sources

Pharmaceutical Industry in Australia

  • Childhood and Adolescence Poisoning in Nsw, Australia: an Analys...
  • September 2014
    6 pages
  • Pharmaceutical  

    Drug And Medica...  

  • Australia  

View report >

Pathology Description

September 2014

1 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.